Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiji Yano

Showing results (51-60 of 286) with videos related to

Pageof 29
Sort By:
Cancer Immunology, Immunotherapy : CII|February 9, 2021
Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor modelsShunsuke Goto, Yukimi Sakoda, Keishi Adachi, et al.
Internal Medicine (Tokyo, Japan)|November 22, 2021
Severe Skin Toxicity Caused by Sequential Anti-PD-1 Antibody and Alectinib in Non-small-cell Lung Cancer: A Report of Two Cases and a Literature ReviewAkihiro Nishiyama, Yoshihiro Hattori, Shinji Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activityHiroaki Muguruma, Seiji Yano, Soji Kakiuchi, et al.
BMC Gastroenterology|July 9, 2015
Intraductal papillary mucinous carcinoma of the pancreas associated with pancreas divisum: a case report and review of the literatureTakeshi Nishi, Yasunari Kawabata, Noriyoshi Ishikawa, et al.
Translational Lung Cancer Research|October 24, 2025
Immune checkpoint inhibitors combined with chemotherapy as first-line treatment may improve clinical outcomes in advanced non-small cell lung cancer with bone metastasesYohei Asano, Katsuhiro Hayashi, Shinji Miwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient miceSeiji Yano, Helong Zhang, Masaki Hanibuchi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 6, 2003
[Tuberculous epididymitis caused by intravesical BCG therapy: a case report]Kazuhiko Ishizu, Hiroshi Hirata, Seiji Yano, et al.
Anticancer Research|August 15, 2002
A fractal dimension analysis: a new method for evaluating the response of anticancer therapyHiroshi Omori, Yoshinori Nio, Seiji Yano, et al.
Clinical & Experimental Metastasis|September 15, 2005
SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cellsRui Zheng, Seiji Yano, Yuka Matsumori, et al.
Cell Cycle (Georgetown, Tex.)|June 14, 2013
KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 familyZanabazar Enkhbaatar, Minoru Terashima, Dulamsuren Oktyabri, et al.
Pageof 29

Showing results (51-60 of 286) with videos related to

Sort By:
Pageof 29
Cancer Immunology, Immunotherapy : CII|February 9, 2021
Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor modelsShunsuke Goto, Yukimi Sakoda, Keishi Adachi, et al.
Internal Medicine (Tokyo, Japan)|November 22, 2021
Severe Skin Toxicity Caused by Sequential Anti-PD-1 Antibody and Alectinib in Non-small-cell Lung Cancer: A Report of Two Cases and a Literature ReviewAkihiro Nishiyama, Yoshihiro Hattori, Shinji Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activityHiroaki Muguruma, Seiji Yano, Soji Kakiuchi, et al.
BMC Gastroenterology|July 9, 2015
Intraductal papillary mucinous carcinoma of the pancreas associated with pancreas divisum: a case report and review of the literatureTakeshi Nishi, Yasunari Kawabata, Noriyoshi Ishikawa, et al.
Translational Lung Cancer Research|October 24, 2025
Immune checkpoint inhibitors combined with chemotherapy as first-line treatment may improve clinical outcomes in advanced non-small cell lung cancer with bone metastasesYohei Asano, Katsuhiro Hayashi, Shinji Miwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient miceSeiji Yano, Helong Zhang, Masaki Hanibuchi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 6, 2003
[Tuberculous epididymitis caused by intravesical BCG therapy: a case report]Kazuhiko Ishizu, Hiroshi Hirata, Seiji Yano, et al.
Anticancer Research|August 15, 2002
A fractal dimension analysis: a new method for evaluating the response of anticancer therapyHiroshi Omori, Yoshinori Nio, Seiji Yano, et al.
Clinical & Experimental Metastasis|September 15, 2005
SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cellsRui Zheng, Seiji Yano, Yuka Matsumori, et al.
Cell Cycle (Georgetown, Tex.)|June 14, 2013
KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 familyZanabazar Enkhbaatar, Minoru Terashima, Dulamsuren Oktyabri, et al.
Pageof 29